Clik here to view.
Zeus Industrial Products, Inc. (“Zeus”)蓄势待发，将在汽车及航空航天市场中谋求发展
爱尔兰莱特肯尼 (美国商业资讯)–Zeus旗下全资子公司Zeus Industrial Products (Ireland), Limited今天宣布，该公司以汽车行业制造商与供应商身份获得ISO/TS16949认证。TS16949以ISO...
View ArticleClik here to view.
サンバイオ、再生細胞薬SB623の網膜変性疾患用途特許を取得
米国カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社およびその子会社であるSanBio...
View ArticleClik here to view.
インサイトとアリアド、インサイトによるアリアドの欧州事業買収と欧州でのイクルーシグ（ポナチニブ）のインライセンスに関する契約を発表
米デラウェア州ウィルミントン & マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View ArticleClik here to view.
SanBio Granted Key Patent in Treatment for Macular Degeneration
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine, today announced it has been granted a key patent by the United States Patent and Trademark Office (USPTO) covering...
View ArticleClik here to view.
Solasia files New Medical Device Application for episil in Japan and China
TOKYO Solasia Pharma K.K. (“Solasia”), a private oncology specialized pharmaceutical company developing oncology products for Asian commercial markets, announced today the filing of a New Medical...
View ArticleClik here to view.
European Scleroderma Trial Investigating Cytori Cell Therapy to Be Presented...
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that on May 18, 2016, an update regarding the French SCLERADEC I and II clinical trials investigating the use of Cytori...
View ArticleClik here to view.
ゼウス・インダストリアル・プロダクツ、自動車および航空宇宙市場での成長態勢を整える
アイルランド・レタケニー （ビジネスワイヤ） — ゼウスの完全所有子会社のゼウス・インダストリアル・プロダクツ（アイルランド）は本日、自動車業界向けメーカーおよびサプライヤーとしてISO/TS16949認定を受けたと発表しました。ISO...
View ArticleClik here to view.
AllCells Introduces CliniCells™ Clinical Grade Products for Further...
ALAMEDA, Calif. AllCells, LLC, (the “company”) today announced registration of its Alameda, CA facilities with the US-FDA enabling the company to immediately provide clinical grade products to...
View ArticleClik here to view.
BioCision to Showcase ThawSTAR CB Thawing System for Cryobags at ISCT 2016
SAN RAFAEL, Calif. BioCision, LLC, a life science research and development company that standardizes processes from research through point-of-care, announced today that they will be showcasing their...
View ArticleClik here to view.
Alvotech Announces Acquisition of Baliopharm
REYKJAVIK, Iceland Alvotech, a powerful player in the field of biopharmaceuticals, today announced that it has entered into a definitive agreement to acquire Baliopharm GmbH, a German...
View ArticleClik here to view.
American Heart Association Recommends Robot-Assisted Movement Training and...
NORWELL, Mass. For patients and therapists, believing in the benefits state-of-the-art robotic medical devices bring to the table is one thing. But having your beliefs incorporated into the official...
View ArticleClik here to view.
HemaCare Attends Cell Therapy Meeting in Singapore
LOS ANGELES HemaCare Corporation,(OTCBB:HEMA) a leader in cell and tissue collection, processing and cell therapy solutions, today announced that it will be attending the ISCT meeting May 25-28th at...
View ArticleClik here to view.
22nd Century将向全球科学家、研究人员和政府提供专利研究香烟
纽约州克拉伦斯 (美国商业资讯) — 植物生物技术公司22nd Century Group, Inc. (NYSE MKT:XXII)是烟草减害领域的领先者，该公司今天宣布上市一系列不同水平尼古丁的新款研究香烟。22nd...
View ArticleClik here to view.
Biological Industries Announces Poster Presentation at International Society...
KIBBUTZ BEIT HAEMEK, Israel & CROMWELL, Conn. Biological Industries (“BI”; www.bioind.com), a leading developer and manufacturer of cell culture media, molecular biology tools, human...
View ArticleClik here to view.
Samsung Bioepis’ Biologics License Application for SB2 Infliximab Biosimilar...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s Biologics License Application (BLA) for SB2, a...
View ArticleClik here to view.
Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to...
BANNOCKBURN, Ill. & SAN FRANCISCO & TOKYO Baxalta Incorporated (NYSE: BXLT), Velocity Pharmaceutical Development, LLC (VPD) and Astellas Pharma Inc. (TSE:4503) today announced that...
View ArticleClik here to view.
“Frontiers in Human Microbiota Symbiotic Interactions” 3rd Annual Meeting of...
HONG KONG The third “Bridging Biomedical Worlds” meeting, entitled “Frontiers in Human Microbiota Symbiotic Interactions” was dedicated to the vital role played by our host microbiota in human...
View ArticleClik here to view.
Dr. Reddy’s Enters the Branded Consumer Health Arena Through the Acquisition...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced the acquisition of an eminent portfolio of over-the-counter (OTC) brands...
View ArticleClik here to view.
Shenyang Research Institute Selects Provantis Preclinical Software Solution...
CONSHOHOCKEN, Pa. Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the Shenyang Research Institute of Chemical Industry (SYRICI) has...
View ArticleClik here to view.
Acucela Announces Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View Article